Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Data Study in HER2+ Metastatic Breast Cancer Patients in Third-Line Therapy

NCT04566458 is registered in ClinicalTrials.gov with Exactis Innovation as lead sponsor.

NCT NCT04566458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04566458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Data Study in HER2+ Metastatic Breast Cancer Patients in Third-Line Therapy
Lead sponsor
Exactis Innovation
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
May 30, 2021
Enrollment
63 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage iv